Relugolix + E2/NETA

Keep browsing

You may also be interested in

Breast cancer screening test

Xemperia flag-ship project is a PCR-based blood test for breast cancer screening.
The technology can be adapted to other cancers, immune, inflammatory and cardiovascular diseases.
Xemperia's pipeline also includes DNA based nansensors for the ultrasensitive detection of nucleic acids.

Phase II completed

Relugolix + E2/NETA

Endometriosis-associated pain.

Phase III started

LakeSai – Accelerating Discovery with AI You Can Trust

LakeSAI is a membership-based AI research agent built for scientists who need faster, deeper and more transparent access to biomedical knowledge. Users interact via natural language or structured data inputs, enabling precise, reproducible and evidence-based exploration.
Explore: https://lakesai.vitafluence.com